Evidence map›Paper›PMID 26719269›Full record

ArticleJournal of virology2015

Plasmacytoid Dendritic Cells Require Direct Infection To Sustain the Pulmonary Influenza A Virus-Specific CD8 T Cell Response.

Emily A Hemann, Louisa E Sjaastad, Ryan A Langlois, Kevin L Legge

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Antigen Presentation in the Lung.Frontiers in immunology · 2022
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Emily A HemannImmunology Graduate Program and Department of Pathology, University of Iowa, Iowa City, Iowa, USA.
Louisa E SjaastadDepartment of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, USA.
Ryan A LangloisDepartment of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, USA Center for Immunology, University of Minnesota, Minneapolis, Minnesota, USA.
Kevin L LeggeImmunology Graduate Program and Department of Pathology, University of Iowa, Iowa City, Iowa, USA Department of Microbiology, University of Iowa, Iowa City, Iowa, USA kevin-legge@uiowa.edu.
University of Iowa · USUniversity of Minnesota · US

Funding

PREDOCTORAL TRAINING PROGRAM IN IMMUNOLOGYT32AI007485 · NIAID · UNIVERSITY OF IOWA · PI Kevin L Legge · 1995 to 2026
$5.4M
Training in Molecular Virology, Viral Pathogenesis and Viral VectorsT32AI007533 · NIAID · UNIVERSITY OF IOWA · PI Stanley Perlman · 1998 to 2026
$2.5M
Role of Dendritic Cells in Immunity to Pulmonary Influenza Virus InfectionsR01AI071085 · NIAID · UNIVERSITY OF IOWA · PI LEGGE, KEVIN L · 2007 to 2011
$1.8M
Role of Dendritic Cells in Immunity to Pulmonary Influenza Virus InfectionsR56AI071085 · NIAID · UNIVERSITY OF IOWA · PI LEGGE, KEVIN L · 2013 to 2013
$350k
NIAID NIH HHS AI071085NIAID NIH HHS R01 AI071085NIAID NIH HHS R56 AI071085NIAID NIH HHS T32 AI007485NIAID NIH HHS T32 AI007533
6 · The paper itself

Abstract

unlabelledFollowing influenza A virus (IAV) infection, development of a robust IAV-specific CD8 T cell response is required for clearance of primary infection and enhances memory protection. Following IAV infection, plasmacytoid dendritic cells (pDC) or CD8α(+) DC regulate pulmonary effector CD8 T cell responses within the lung. Without this DC-T cell interaction, insufficient effector CD8 T cells are maintained in the lungs, leading to enhanced morbidity and mortality. Previous studies have demonstrated that pDC are capable of classical presentation or cross-presentation of IAV antigens and could potentially regulate IAV-specific CD8 T cell responses through either mechanism. Our results demonstrate that pDC from the lungs of donor mice infected with an IAV that is not able to replicate in hematopoietic cells (142t-IAV), unlike donor pDC isolated from the lungs of control infected mice, are not able to rescue the host IAV-specific CD8 T cell response from apoptosis. This indicates that pDC must utilize the direct presentation pathway for this rescue. This inability of pDC from 142t-IAV donors to rescue the IAV-specific CD8 T cell response is not due to differences in the overall ability of 142t-IAV to replicate within the lungs or generate defective viral genomes or to differences in levels of costimulatory molecules required for this interaction. We further demonstrate that bypassing the antigen presentation pathway by coating the 142t-IAV pDC with IAV peptide epitopes restores their ability to rescue the IAV-specific CD8 T cell response. IMPORTANCE: IAV continues to be a global health burden, infecting 5 to 20% of the global population annually. Continued investigation into the mechanisms that mediate protective immune responses against IAV is important to improving current vaccination and antiviral strategies antagonistic toward IAV. Our findings presented herein demonstrate a key requirement for pDC promotion of effector CD8 T cell survival: that rather than utilizing cross-presentation, pDC must be infected and utilize the endogenous pathway for presentation of antigens to CD8 T cells during in vivo IAV infections. This suggests that targeting presentation via the endogenous pathway in pDC could be important for the development of unique antiviral cellular therapies.

Indexed as

AnimalsCD8-Positive T-LymphocytesDendritic CellsInfluenza A virusLungMice, Inbred BALB C

Identifiers

PMID26719269
PMCPMC4810669
OpenAlexW2217020760

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.